ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 353451 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 353451; 2) Community: the network communities that were significantly associated with the response to NSC 353451; 3) Molecule: the relationships between components within communities and NSC 353451; 4) MDR: the compounds that were significantly associated with the NSC 353451.

NSC Compound Enrichment Correlation
NSC 715755 Null 0.0459335986102865 0.02836098
NSC 724601 S-(dimethylarsino)-3-mercapto-1,2-propyl dinonanoate 0.0459335986102865 0.04646776
NSC 726262 1,1'-{[(bispropane-1,N-diyl)piperzine]dioxy}bis[(11aS)-7-met hoxy-1,2,3,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepi n-5-one 0.0459335986102865 0.34532121
NSC 744025 diethyl 2-[4-(5-[(11aS)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxypentyl)piperazino]ethylphosphonate 0.0459335986102865 0.43166835
NSC 9037 Null 0.0459335986102865 0.27172393
NSC 109555 DDUG 0.048939380959983 0.062926874
NSC 123491 L-Cysteine, S-[tris(4-methylphenyl)methyl]- (9CI) 0.048939380959983 0.024045389
NSC 149501 Bleomycinamide, N(1)-[3-[(4-aminobutyl)amino]propyl]-, sulfate (salt) 0.048939380959983 0.60049443
NSC 19441 FDA 0283 0.048939380959983 0.30948609
NSC 210717 Ellipticine, 9-hydroxy-, hydrochloride 0.048939380959983 0.36634626
Total:34  Current:31    [First] [Prev] [Next] [Last]